[Iodine, sodium-iodine symporter and thyroid diseases]

Area of Science:

• Endocrinology
• Molecular Biology
• Cell Biology

Background:

• The sodium-iodide symporter (NIS) is crucial for iodine uptake in thyroid cells, a key step in thyroid hormone synthesis.
• Thyroid-stimulating hormone (TSH) regulates NIS gene expression, influencing thyroid function.
• Cytokines can modulate TSH-induced NIS gene induction.

Purpose of the Study:

• To analyze the distribution and expression levels of NIS mRNA across various thyroid tissue samples.
• To investigate the role of NIS in different thyroid pathologies, including adenomas, Graves' disease, Hashimoto's disease, nodules, and cancers.
• To explore potential NIS gene defects in congenital hypothyroidism and other thyroid diseases.

Main Methods:

• Analysis of NIS mRNA distribution in different tissue samples.
• Comparison of NIS expression levels in healthy thyroid tissue versus diseased states.
• Investigation of NIS gene mutations in patients with congenital hypothyroidism.

Main Results:

• Variable levels of NIS transcription were observed in different tissue samples.
• Increased NIS expression was noted in Graves' disease and autonomous adenomas.
• Decreased NIS protein and/or mRNA levels were found in Hashimoto's disease, cold nodules, and most thyroid cancers.
• NIS mutations were identified in cases of congenital hypothyroidism.

Conclusions:

• NIS expression is altered in various thyroid conditions, impacting iodine uptake and thyroid hormone synthesis.
• NIS gene defects are implicated in congenital hypothyroidism, warranting further investigation.
• Understanding NIS expression patterns is vital for diagnosing and managing thyroid diseases.